• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IV期肾细胞癌。

Stage IV renal cell carcinoma.

作者信息

Frank W, Stuhldreher D, Saffrin R, Shott S, Guinan P

机构信息

Department of Urology, University of Illinois, Chicago.

出版信息

J Urol. 1994 Dec;152(6 Pt 1):1998-9. doi: 10.1016/s0022-5347(17)32289-9.

DOI:10.1016/s0022-5347(17)32289-9
PMID:7966660
Abstract

Data from 104 patients with stage IV renal cell carcinoma were evaluated to investigate relationships between survival and gender, race, age, tumor size, lung versus bone metastasis, number of metastatic sites and nephrectomy. No statistically significant differences in survival were found between gender or racial groups, nor was there a statistically significant relationship between survival and patient age. Survival tended to decrease as tumor size increased. Survival was worse for patients with multiple metastatic sites compared to those with only 1 metastatic site, and for patients with bone and lung metastases compared to those with lung but no bone metastases and bone but no lung metastases. Although nephrectomy patients appeared to have somewhat better survival rates than those without nephrectomy, this difference was apparently due to better prognostic factors for nephrectomy patients.

摘要

对104例IV期肾细胞癌患者的数据进行评估,以研究生存与性别、种族、年龄、肿瘤大小、肺转移与骨转移、转移部位数量及肾切除术之间的关系。性别或种族组之间在生存方面未发现有统计学意义的差异,生存与患者年龄之间也没有统计学意义的关系。生存倾向于随着肿瘤大小的增加而降低。与仅有1个转移部位的患者相比,有多个转移部位的患者生存情况更差;与有肺转移但无骨转移以及有骨转移但无肺转移的患者相比,有骨和肺转移的患者生存情况更差。尽管接受肾切除术的患者似乎比未接受肾切除术的患者生存率略高,但这种差异显然是由于接受肾切除术的患者具有更好的预后因素。

相似文献

1
Stage IV renal cell carcinoma.IV期肾细胞癌。
J Urol. 1994 Dec;152(6 Pt 1):1998-9. doi: 10.1016/s0022-5347(17)32289-9.
2
Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.非透明细胞组织学类型的转移性肾细胞癌的减瘤性肾切除术。
J Urol. 2007 Nov;178(5):1896-900. doi: 10.1016/j.juro.2007.07.037. Epub 2007 Sep 17.
3
Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).肾切除术时淋巴结清扫范围影响肾细胞癌(RCC)特定亚组患者的癌症特异性生存率和转移进展。
BJU Int. 2014 Aug;114(2):210-5. doi: 10.1111/bju.12508. Epub 2014 May 22.
4
Long-term results of simple and radical nephrectomy for renal cell carcinoma.肾细胞癌单纯性肾切除术和根治性肾切除术的长期结果。
Cancer. 1991 May 15;67(10):2506-11. doi: 10.1002/1097-0142(19910515)67:10<2506::aid-cncr2820671020>3.0.co;2-y.
5
Prognostic factors and value of adjunctive nephrectomy in patients with stage IV renal cell carcinoma.
Urology. 1991 Feb;37(2):95-9. doi: 10.1016/0090-4295(91)80200-q.
6
Assessment of survival of patients with metastatic clear cell renal cell carcinoma after radical cytoreductive nephrectomy versus no surgery: a seer analysis.转移性透明细胞肾细胞癌患者根治性细胞减灭性肾切除术后与未手术患者生存率的评估:一项监测、流行病学和最终结果(SEER)分析
Int Braz J Urol. 2015 Mar-Apr;41(2):288-95. doi: 10.1590/S1677-5538.IBJU.2015.02.15.
7
Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma.转移灶的数量而非位置决定了淋巴结阴性转移性肾细胞癌患者的总生存期。
Urology. 2003 Feb;61(2):314-9. doi: 10.1016/s0090-4295(02)02163-5.
8
Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.孤立肾肾细胞癌:保留肾单位手术后并发症及预后分析
J Urol. 2002 Aug;168(2):454-9. doi: 10.1016/s0022-5347(05)64657-5.
9
Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.保留肾单位手术治疗肾细胞癌的疗效:基于1997年新的肿瘤-淋巴结-转移分期系统的分析。
J Clin Oncol. 1999 Sep;17(9):2868-75. doi: 10.1200/JCO.1999.17.9.2868.
10
Survival after complete surgical resection of multiple metastases from renal cell carcinoma.肾细胞癌多发转移完全手术后的生存情况。
Cancer. 2011 Jul 1;117(13):2873-82. doi: 10.1002/cncr.25836. Epub 2011 Jan 10.

引用本文的文献

1
Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor.通过原发性肿瘤的基因表达谱预测转移性肾癌患者的生存率。
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):6958-63. doi: 10.1073/pnas.1131754100. Epub 2003 May 30.
2
Multivariate evaluation of prognostic determinants for renal cell carcinomas which are metastatic at initial diagnosis.
Int Urol Nephrol. 1997;29(3):291-300. doi: 10.1007/BF02550925.